Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
Ontology highlight
ABSTRACT: Memories associated with drug use increase vulnerability to relapse in substance use disorder (SUD), and there are no pharmacotherapies for the prevention of relapse. Previously, we reported a promising finding that storage of memories associated with methamphetamine (METH), but not memories for fear or food reward, is vulnerable to disruption by actin depolymerization in the basolateral amygdala complex (BLC). However, actin is not a viable therapeutic target because of its numerous functions throughout the body. Here we report the discovery of a viable therapeutic target, nonmuscle myosin IIB (NMIIB), a molecular motor that supports memory by directly driving synaptic actin polymerization. A single intra-BLC treatment with Blebbistatin (Blebb), a small-molecule inhibitor of class II myos
SUBMITTER: Young EJ
PROVIDER: S-EPMC4740255 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
ACCESS DATA